Ranchi sadar hosp to start CT scan services this week
2
Ranchi: The Ranchi sadar hospital will roll out CT scan services later this week for its patients, its management said on Monday.
A three-day trial run of the machine, which will be operated under public-private partnership (PPP) mode, began on Sunday.
"The facility will be fully functional and open to patients after the trial. An MRI machine will also be installed in 15 days," civil surgeon Dr Prabhat Kumar said.
The hospital's MoU with Krishna Diagnostics mandate that all patients admitted under the Ayushman Bharat health scheme will be provided with free CT scan services. For others, tests will be conducted based on the Central Govt Health Scheme (CGHS) rates, beginning from Rs 1,050.
Dr Kumar said, "An added benefit of the partnership is the revenue-sharing clause outlined in the MoU. Krishna Diagnostics will share 15% of its profits with the Sadar Hospital. These funds would contribute to the development of hospital infrastructure and services, benefiting patients."
The hospital would also set up a Cath Lab for cardiac care. This facility, being constructed at a cost of around Rs 8 crore, will provide advanced treatment options for heart patients, reducing the need for referrals to private hospitals.
Lauding the move, Rekha Devi of Kanke said, "I was delaying a test as the price of CT scans in private centres was beyond my reach. Undergoing the test at the sadar hospital will save both money and time."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
40 minutes ago
- Indian Express
Lenskart's IPO in-sight: What it reveals about optometrists, screen time, and global bets
Too much screen time, too few optometrists, and one company going global – Lenskart's IPO filing reveals more than just financials. The eyewear unicorn, which clocked Rs 6,653 crore in revenue in 2024-25 (FY25) and turned profitable (Rs 297 crore) for the first time, is looking to raise Rs 2,150 crore through a fresh issue. Over 13 crore shares will also be offloaded via an offer for sale, with early investors such as SoftBank and Schroders Capital expected to cash out. But beyond the numbers, its draft red herring prospectus (DRHP) offers a lens into deeper trends shaping India's $10-billion eyewear market: worsening eye health among children, limited access to prescription eyewear, and the high-stakes balancing act of building a global brand from India. In India, the prevalence of refractive errors that cause blurry vision has grown rapidly among those under 19 years – from 21 per cent in FY20 to 39 per cent in FY25. For the overall population, the growth was relatively slower from 43 per cent to 53 per cent, according to Redseer research cited in Lenskart's DRHP. In the next five years, Redseer projects more than half (54 per cent) of children and teenagers will have refractive errors requiring prescription eyewear. 'Contributors include excessive screen time, particularly late-night smartphone use, prolonged near-work activities like reading and studying, limited exposure to natural light due to reduced outdoor play, and poor visual habits such as incorrect posture and inadequate lighting,' the DRHP said. The condition is more common in metro cities (64 per cent) than in tier-1 (59 per cent) or other cities (52 per cent). While India's overall prevalence (53 per cent) is lower than in Japan (68 per cent) and Southeast Asia (65 per cent), it still exceeds that of the Middle East (40 per cent) – and is expected to rise to 62 per cent by FY30. Though over half of Indians face refractive errors, only 35 per cent wore prescription eyewear in FY25, lagging Southeast Asia (40 per cent), the Middle East (60 per cent), and Japan (69 per cent). The penetration rate is expected to increase only slightly to 41 per cent by FY30, indicating that the market will remain heavily underserved, according to Redseer. Why? The World Council of Optometry (WCO) recommends 100 optometrists per million people, but India has just 35-50 such professionals trained to test vision and prescribe corrective lenses. In Japan, the figure stands at 80-100 per million, 110 in the US, and 200 in Singapore. Moreover, India has far fewer eyewear stores (60 per million people) compared to pharmacies (350-450) or jewellery stores (1,000-1,200). Over 70 per cent of prescription eyewear is still sold through unorganised channels, with just 11-13 per cent via D2C brands like Lenskart and Titan Eye+. 'We may face difficulties in finding, training and retaining qualified opticians and optometrists, especially in Tier 2 and 3 cities, where the availability and awareness of such professionals may be lower than in Tier 1 cities,' the DRHP said. Unlike most Indian-origin D2C brands, Lenskart has built a sizable overseas footprint, with international customers contributing 40 per cent of its FY25 revenue. The company operates over 2,000 stores in India, more than 250 each in Japan and Southeast Asia, around 40 in the Middle East, and another 100 across Taiwan, Hong Kong, and Australia. Its presence in Asia was bolstered by the 2022 acquisition of Japanese eyewear brand OWNDAYS. In 2024, Lenskart made a minority investment in French brand Le Petit Lunetier, launching its products in India. More recently, it acquired an 80 per cent stake in Spanish sunglasses label Meller. While Lenskart's global reach gives it access to higher-margin markets, it also heightens its exposure to supply chain risks – particularly due to its reliance on imports from China, where it holds a 51 per cent stake in a joint venture that manufactures frames. 'Rising nationalism, protectionist policies, or shifts in customer sentiment against products associated with Chinese supply chains could further reduce demand. If we are unable to address these risks, or adapt to evolving market conditions, our business, results of operations, and financial condition could be affected,' the DRHP said. In some good news, China's share in Lenskart's raw material imports has declined – from 54 per cent in FY23 to 42 per cent in FY25. Today, 98 per cent of its prescription eyewear is manufactured in Gurgaon and Bhiwadi, with the rest produced in Singapore and Dubai. A new Rs 1,500-crore greenfield facility for optical glasses near Hyderabad is also in the works. Aggam Walia is a Correspondent at The Indian Express, reporting on power, renewables, and mining. His work unpacks intricate ties between corporations, government, and policy, often relying on documents sourced via the RTI Act. Off the beat, he enjoys running through Delhi's parks and forests, walking to places, and cooking pasta. ... Read More
Indian Express
2 hours ago
- Indian Express
Dead infant kept for days on ventilator in Ranchi hospital, parents claim; FIR filed
The parents of an infant alleged that a private hospital in Ranchi, where he was admitted last month, hid his death from them and kept the body on ventilator for several days. The hospital has denied the allegations. Police have registered an FIR in the case, and Ranchi Deputy Commissioner Manjunath Bhajantri said a three-member team had been formed to investigate the matter. 'After the child died, the body was allegedly kept on a ventilator and began decaying. The body was emitting a foul smell. And the child's parents come from a very poor family,' Bhajantri said. The baby was born on July 4 at Ranchi Sadar Hospital and was moved to Little Heart Hospital on July 8 after the family noticed signs of oxygen deficiency. A doctor from the hospital, Dr Satyajeet Kumar, said in a press conference on Sunday that the baby was alive until he was discharged from the hospital 'against medical advice' on July 30. He also rejected allegations that the hospital had hidden the baby's death and presented what he said were photographs and time-stamped medical monitor screenshots from the day the baby was handed over to the family. He insisted that the baby was not showing signs of decomposition. The baby's father, Mukesh Singh, an auto-rickshaw driver, told The Indian Express that after the baby was admitted to the private hospital, the family was denied even 10 minutes with the baby. He said that the family borrowed around Rs 3 lakh for the treatment. Mukesh said that on July 12, after repeatedly insisting, the hospital sent them a video in which the baby appeared to be alive. But two to three days later, they sent the exact same video again, raising suspicions, he claimed. 'At no point were we allowed to verify the baby's condition in person. Whenever we demanded to see him, the hospital would send pre-recorded videos, citing 'swelling' as the reason for the bloated appearance,' he claimed. 'After a week, I started doubting whether my baby was even alive. But I couldn't bring myself to ask anyone out of fear of hearing the worst,' he said. On July 30, the hospital handed over the baby, Mukesh said. However, he alleged that the baby had been dead for days, as the body was bloated and emitting a foul smell. The hospital issued a statement rejecting all accusations made against it. In a press conference on Sunday, Dr Satyajeet Kumar, who was among those who treated the infant, said the baby was admitted on July 8 with severe respiratory distress and infection. 'The baby was in septic shock. We admitted him without waiting for formalities like registration or payment.' He said the child showed vital signs, heartbeat, movement, and oxygen saturation until July 30. 'Monitor readings showed 94% oxygen saturation. The baby was moving and breathing irregularly. These are not signs of a dead body,' he said. He further said that the family insisted on taking the baby home despite being warned of the critical condition. 'We explained the risks clearly, but they insisted. So we completed formalities and handed the child over in a living state,' he said. Brahmdev Prasad, the officer in charge of Argora police station, said an FIR was registered. He said an investigation is underway. Deputy Commissioner Manjunath Bhajantri told The Indian Express, 'A probe is underway. A team comprising a doctor nominated by the Civil Surgeon, an Executive Magistrate, and the District Social Welfare Officer has been formed.' 'Action will be taken based on the committee's findings. I was told that a complaint has been lodged at Argora police station, but we will also separately see that issue. The matter may also fall under provisions of the Clinical Establishment Act. We will act accordingly,' Bhajantri said. BJP state president and Jharkhand's Leader of Opposition, Babulal Marandi weighed in on the case, calling it an 'inhuman act'. Shubham Tigga hails from Chhattisgarh and studied journalism at the Asian College of Journalism. He previously reported in Chhattisgarh on Indigenous issues and is deeply interested in covering socio-political, human rights, and environmental issues in mainland and NE India. Presently based in Pune, he reports on civil aviation, other transport sectors, urban mobility, the gig economy, commercial matters, and workers' unions. You can reach out to him on LinkedIn ... Read More
Time of India
3 hours ago
- Time of India
Want to upgrade your health insurance cover? Here's why top-up, not new policy is the way to go
Academy Empower your mind, elevate your skills Content on this page is courtesy Centre for Investment Education and Learning (CIEL). Contributions by Girija Gadre, Arti Bhargava and Labdhi Mehta. Nitin Khurana has been paying the premium for a health insurance policy of Rs.10 lakh for himself and his wife. With rising healthcare costs and age, he realises that the amount is not enough. As he was debating whether he should enhance his cover to Rs.15 lakh or take an additional Rs.5 lakh policy, he came across top-up plan s. How should he increase his cover? Should he get a new policy or a top-up plan?Nitin Khurana's concern about the insufficient cover that his existing health policy provides is justified. A serious illness or an accident may require expensive treatment and exhaust his health cover . So he needs to increase it. A top-up plan is an additional coverage at a lower cost for people who have an existing health policy. It takes care of expenses that result from a single illness, but are higher than the cover provided by the existing plan. Since it provides the necessary additional coverage at a low cost, a top-up plan makes sense for has the option to buy a new regular health policy with a Rs.5 lakh cover, or can upgrade his existing plan by Rs.5 lakh. However, both these work out as expensive options. A top-up plan worth Rs.5 lakh, on the other hand, will cost much less. The cost of the top-up plan is linked to a factor called 'deductible limit'. It is a predecided limit mentioned in the schedule and only when the cost of a single illness crosses this limit does the top-up plan kick in. The higher the deductible, the cheaper the top-up plan. The primary policy reduces the risk for the insurer.A top-up plan generally covers only single-incidence hospitalisation. This means that the top-up plan kicks in only if the hospital bill exceeds the deductible limit during a single hospitalisation. Some plans do not come with the limit of a single claim and can be used for any illness beyond the deductible limit for the entire year. These plans are known as super top-ups Top-up health plans are designed to enhance the existing policies to cover the actual healthcare costs. The point is not to duplicate but to buy additional coverage at a reasonable cost. Top-up plans ensure that there is sufficient cover and that insurance does not run out when the actual need arises.
